Allan Mark Watson

Allan Mark Watson

Director/Board Member at Kyowa Kirin International Plc

57 year
Health Technology
Commercial Services
Consumer Services

Profile

Allan Mark Watson is currently a Director at Kyowa Kirin International Plc, Archimedes Pharma Ltd., Kyowa Kirin Pharmaceutical Development Ltd., Kyowa Kirin Ltd., Kyowa Kirin Services Ltd., Stirling Anglian Pharmaceuticals Ltd., and Kelso Pharma Ltd.
He previously served as a Director at Archimedes Pharma UK Ltd.
from 2014 to 2020.
Prior to that, he was the Co-Managing Director at Kyowa Kirin GmbH.
Mr. Watson also worked as the Chief Financial Officer at Optos Plc from 2003 to 2009.
He obtained his undergraduate degree from The Robert Gordon University.

Allan Mark Watson active positions

CompaniesPositionStart
Director/Board Member 2009-09-08
Director/Board Member 2014-08-04
Director/Board Member 2009-09-08
Director/Board Member 2009-09-08
Director/Board Member 2014-08-04
Director/Board Member 2021-01-05
Director/Board Member 2021-12-20
All active positions of Allan Mark Watson

Former positions of Allan Mark Watson

CompaniesPositionEnd
Director/Board Member 2020-04-21
OPTOS PLC Director of Finance/CFO 2009-08-30
░░░░░ ░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -
See the detail of Allan Mark Watson's experience

Training of Allan Mark Watson

The Robert Gordon University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Allan Mark Watson's experience

Connections

40

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Allan Mark Watson
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW